THU0193 Response To Baricitinib at 4 Weeks Predicts...

THU0193 Response To Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies: Table 1.

Weinblatt, M., Taylor, P., Tanaka, Y., Keystone, E., Schiff, M., Fleischmann, R., Yang, L., Arora, V., de Bono, S., Holzkaemper, T., Schlichting, D., Takeuchi, T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-eular.1597
Date:
June, 2016
File:
PDF, 109 KB
english, 2016
Conversion to is in progress
Conversion to is failed